Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL. Han Q, Gu Y, Xiang H, Zhang L, et al. Blood 2025;145:1407-1421.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han Q, Gu Y, Xiang H, Zhang L, et al. Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL. Blood 2025;145:1407-1421.
PMID: 39785511